Welcome to the 2026 ISPE Annual Conference.

**Please Note: Listed times are for Central European Summer Time (CEST)**

INSTRUCTIONS

INSTALL ZOOM IN ADVANCE

You will be using Zoom to watch the live stream sessions. For the best experience, you are encouraged to install the desktop application in advance, which you can find by clicking here. A registered Zoom account is NOT required to connect and stream sessions.

ACCESSING INDIVIDUAL SESSIONS

Click on the session that you would like to view. You will be prompted to add your name and email and click “register.” After you click register, if the session has not yet begun, you will see a “holding message” until the sessions starts.

If you need to re-join a session, close Zoom and click again on the session link located on the ISPE webpage. Anytime you join a Zoom session, you will be asked to re-enter your details.

Zoom’s Chat function cannot be used to direct questions to presenters on-site in Milan. The Chat is purely for attendees connected to the live stream channel.

TECHNICAL ISSUES

If you have any technical difficulties during the session, please visit our support page.

Plenary Session 1

8:00 AM – 10:00 AM CEST

Welcome to ISPE 2026 and Keynote Session: Peter R. Arlett, MD

Oral Presentations Session 1

10:30 AM – 12:00 PM CEST

1A – Will AI Steal Our Jobs?

10:30 AM – 12:00 PM CEST

1B – Brain, Bones, Blood Sugar: Medication Effects in Older Adults

10:30 AM – 12:00 PM CEST

1C – Vaccines: Novel Approaches for Assessing Safety, Effectiveness, and Use

10:30 AM – 12:00 PM CEST

1D – Signal, Evidence, Action: Advancing Drug Safety Science

10:30 AM – 12:00 PM CEST

1E – Going for the Gold: Oncology RWD Safety

10:30 AM – 12:00 PM CEST

1F – Lightning: Three Panels on Methods

10:30 AM – 12:00 PM CEST

1G – Cardiometabolic indications of use and cardiometabolic effects of diabetes medications

Symposia & Workshops: Session 1

1:30 PM – 3:00 PM CEST

SW-1A – When Machines Do the Science: If and When We Trust Agentic AI in Pharmacoepidemiology

1:30 PM – 3:00 PM CEST

SW-1B – From inception to reporting: the resources you need for flawless target trial emulation

1:30 PM – 3:00 PM CEST

SW-1C – Timing Is Everything: Leveraging Time-to-Event Approaches in Perinatal Pharmacoepidemiology

1:30 PM – 3:00 PM CEST

SW-1D – Towards the use of real-world data for regulatory and health technology assessment decision-making: Results from five EU-funded projects

1:30 PM – 3:00 PM CEST

SW-1E – Enhancing peer review of pharmacoepidemiology manuscripts: Perspectives from the Editors of Pharmacoepidemiology & Drug Safety

1:30 PM – 3:00 PM CEST

SW-1F – Emerging Methods for Studying Drug-Environment Interactions

1:30 PM – 3:00 PM CEST

SW-1G – Who checks the code and how? Current gaps and emerging solutions for review and validation of analytical code

Oral Presentations: Session 2

3:30 PM – 5:00 PM CEST

2A – Out of Sight, Not Out of Mind: Treatment Effects Under Censoring

3:30 PM – 5:00 PM CEST

2B – Being methodologic in drug utilization: Navigating Definitions, Patterns, and Real-World Challenges

3:30 PM – 5:00 PM CEST

2C – How Do Exposed Pregnancies End?

3:30 PM – 5:00 PM CEST

2D – No Small Risks: Understanding Safety in Pediatric Vaccination and Treatment

3:30 PM – 5:00 PM CEST

2E – Transforming Cardiovascular Pharmacotherapies: Safety and Effectiveness of Emerging Drug Classes

3:30 PM – 5:00 PM CEST

2F – Serious Safety Outcomes in Neuropsychiatric Patients

3:30 PM – 5:00 PM CEST

2G – A Systems View of Health: Integrating Environmental Exposures, Equity, and Real-World Outcomes

Symposia & Workshops: Session 2

5:15 PM – 6:45 PM CEST

SW-2A – Systematic Drug Repurposing Research Using Healthcare Databases: Methods for Large-Scale Discovery and Evaluation

5:15 PM – 6:45 PM CEST

SW-2B – Medication Adherence Trajectories Modelling: A Review of Implementation, Reporting Practices, and Pitfalls

5:15 PM – 6:45 PM CEST

SW-2C – Less May Be More—for Everyone? Advancing the Science of Deprescribing

5:15 PM – 6:45 PM CEST

SW-2D – Identify, Quantify and Act: Advancing Methods for Reducing Bias from Measurement Error

5:15 PM – 6:45 PM CEST

SW-2E – Data Are Not Enough – Communication Practices for Pharmacoepidemiologists in a Complex Information Ecosystem

5:15 PM – 6:45 PM CEST

SW-2F – The Great Debate by Members of the Academic Council: Use of Artificial Intelligence by Students

5:15 PM – 6:45 PM CEST

SW-2G – Fake World Data, Real World Problems—Simulations for the pharmacoepidemiologist

Oral Presentations: Session 3

8:15 AM – 9:45 AM CEST

3A – Diabetes medications and safety outcomes

8:15 AM – 9:45 AM CEST

3B – Medicines, Methods, and Meaning: Pediatric Pharmacoepidemiology in the Real World

8:15 AM – 9:45 AM CEST

3C – One Size Does Not Fit All

8:15 AM – 9:45 AM CEST

3D – Your AI in action: data handling, classification and prediction

8:15 AM – 9:45 AM CEST

3E – Risk Happens: Infections, Injuries, and Vaccines in Older Adults

8:15 AM – 9:45 AM CEST

3F – Lightning: Drug Safety Effectiveness

8:15 AM – 9:45 AM CEST

3G – Catching What We Miss: Negative Controls and Signal Detection

Plenary Session 2

10:15 AM – 11:30 AM CEST

Hot Topic Session; Acetaminophen (paracetamol) and Autism: Evidence interpretation and communication

Symposia & Workshops: Session 3

1:00 PM – 2:30 PM CEST

SW-3A – Navigating the AI Era in Pharmacovigilance – Pharmacoepidemiology Beyond Traditional Methods

1:00 PM – 2:30 PM CEST

SW-3B – How Patients are Different – Making data linkage and research more fit-for-purpose for therapeutic and regulatory decisions

1:00 PM – 2:30 PM CEST

SW-3C – Real-World Evidence in Regulatory Decision-Making: Lessons Learned from Recent FDA Approvals and the Advancing RWE Program

1:00 PM – 2:30 PM CEST

SW-3D – How I Learned to Stop Worrying and Start Including People in Studies Multiple Times

1:00 PM – 2:30 PM CEST

SW-3E – A Missing Link for Improving Patient Health Outcomes? Adding Nutritional Assessment to the Pharmacoepidemiology Toolbox

1:00 PM – 2:30 PM CEST

SW-3F – Tomorrow’s Evidence 2.0: Replace, Refine, or Reframe the Evidence Pyramid? A Live Framework Build

1:00 PM – 2:30 PM CEST

SW-3G – Workshop: Having patients – Improving patient involvement in RWD research

Plenary Session 3

2:45 PM – 4:00 PM CEST

AGM & Awards Ceremony

Oral Presentations: Session 4

4:15 PM – 5:45 PM CEST

4A – What Gets Measured Gets Estimated

4:15 PM – 5:45 PM CEST

4B – Beyond the Prescription: Evolving Patterns in Antipsychotic and Psychotropic Drug Utilization

4:15 PM – 5:45 PM CEST

4C – When Early Conditions Shape What Follows

4:15 PM – 5:45 PM CEST

4D – Balancing Maternal Outcomes and Infant Risks in Mental Health

4:15 PM – 5:45 PM CEST

4E – Pain across indications: real-world effects of treatment

4:15 PM – 5:45 PM CEST

4F – Transforming Cardiovascular Drug Evidence: Effectiveness Studies And Target Trial Emulation

4:15 PM – 5:45 PM CEST

4G – Targeted Therapies, Real-World Safety and Effectiveness

Oral Presentations: Session 5

8:30 AM – 10:00 AM CEST

5A – Delivering Meaningful Answers in Clinical Decision-Making for Prenatal Exposures

8:30 AM – 10:00 AM CEST

5B – Average is Overrated: Heterogeneity of Treatment Effects

8:30 AM – 10:00 AM CEST

5C – Function Over Fashion: Innovative Control Designs in Oncology

8:30 AM – 10:00 AM CEST

5D – Miscuglio: A Mixture of Safety and Autoimmune Pharmacoepi Outcomes

8:30 AM – 10:00 AM CEST

5E – Evidence to Action: Informing Cardiovascular Drug Safety and Effectiveness

8:30 AM – 10:00 AM CEST

5F – Three Panels on Drug Utilization

8:30 AM – 10:00 AM CEST

5G – Neuropsychiatric Safety in the Elderly

Symposia & Workshops: Session 4

10:30 AM – 12:00 PM CEST

SW-4A – Negative Controls in the Spotlight – recent developments and best practice

10:30 AM – 12:00 PM CEST

SW-4B – Applying Transportability Methods to Rare Diseases: Methods, Applications, and Considerations for Decision-Making

10:30 AM – 12:00 PM CEST

SW-4C – Externally Controlled Trials (ECT) for Evidence Generation in Regulatory Decision-Making: challenges, emerging frameworks, and regulatory use cases

10:30 AM – 12:00 PM CEST

SW-4D – ICPE Geriatric SIG-endorsed Symposium Proposal: Target Trial Emulation for Deprescribing Research and Emerging AI Applications

10:30 AM – 12:00 PM CEST

SW-4E – Driving High Quality RWE in Oncology: Integration, Validation, and AI Harmonization

10:30 AM – 12:00 PM CEST

SW-4F – Spot the AI Slop: AI-Generated Content in Real-World Evidence Publications and its Implications for Systematic Literature Reviews

10:30 AM – 12:00 PM CEST

SW-4G – Right on Time: Practical Approaches to Mitigating Time-Related Biases in Target Trial Emulation for Oncology

Oral Presentations: Session 6

1:30 PM – 3:00 PM CEST

6A – What are we assuming?

1:30 PM – 3:00 PM CEST

6B – From Antibiotics to Antidiabetics and Weight Loss: Evolving Patterns in Drug Utilization

1:30 PM – 3:00 PM CEST

6C – Cardiometabolic Treatments in Pregnancy

1:30 PM – 3:00 PM CEST

6D – Signals to Sequelae: Modern Methods in Disease Course Epidemiology

1:30 PM – 3:00 PM CEST

6E – Designing the Trial We Wish We Ran: Target Trial Emulation in Pediatrics

1:30 PM – 3:00 PM CEST

6F – Beyond the Numbers: Real-World Economics and Outcomes Driving Decisions

1:30 PM – 3:00 PM CEST

6G – Unintended beneficial effects of diabetes medications

Plenary Session 4

3:15 PM – 4:45 PM CEST

Plenary: Advanced Therapy Medicinal Products

4:45 PM – 5:15 PM CEST

The Final Word